Skip to content
healthcare.dev

Griseofulvin

NDC 62135-968, Griseofulvin (microsize), suspension, from Chartwell RX, LLC..

Product NDC
62135-968
Status
Listed
Labeler
Chartwell RX, LLC.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA065200
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-968 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GRISEOFULVIN125 mg/5mL

Pharmacologic classes

Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]

Package NDCNDC-11Package
62135-968-4162135096841120 mL in 1 BOTTLE (62135-968-41)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9f7e4ecf-f992-42c5-81ea-91e6587b22a5
  • NADAC price for package 62135096841

    GET /v1/drugs/nadac/62135096841

Use it

Look up 62135-968 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-968 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-968. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.